Citation: Sr. Pliszka, COMORBIDITY OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER WITH PSYCHIATRIC-DISORDER - AN OVERVIEW/, The Journal of clinical psychiatry, 59, 1998, pp. 50-58
Citation: Sr. Pliszka et Jt. Mccracken, CATECHOLAMINES IN ADHD - A POSTSCRIPT, Journal of the American Academy of Child and Adolescent Psychiatry, 36(7), 1997, pp. 869-870
Citation: Rl. Olvera et al., AN OPEN TRIAL OF VENLAFAXINE IN THE TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER IN CHILDREN AND ADOLESCENTS/, Journal of child and adolescent psychopharmacology, 6(4), 1996, pp. 241-250
Citation: Sr. Pliszka et al., CATECHOLAMINES IN ATTENTION-DEFICIT HYPERACTIVITY DISORDER - CURRENT PERSPECTIVES, Journal of the American Academy of Child and Adolescent Psychiatry, 35(3), 1996, pp. 264-272
Authors:
PLISZKA SR
MAAS JW
JAVORS MA
ROGENESS GA
BAKER J
Citation: Sr. Pliszka et al., URINARY CATECHOLAMINES IN ATTENTION-DEFICIT HYPERACTIVITY DISORDER WITH AND WITHOUT COMORBID ANXIETY, Journal of the American Academy of Child and Adolescent Psychiatry, 33(8), 1994, pp. 1165-1173
Authors:
PLISZKA SR
HATCH JP
BORCHERDING SH
ROGENESS GA
Citation: Sr. Pliszka et al., CLASSICAL-CONDITIONING IN CHILDREN WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD) AND ANXIETY DISORDERS - A TEST OF QUAYS MODEL, Journal of abnormal child psychology, 21(4), 1993, pp. 411-423